Skip to main content
. 2021 Oct 1;21:473. doi: 10.1186/s12872-021-02287-w

Table 3.

Postoperative clinical course over 30 days

TMZ
(n = 40)
Placebo
(n = 40)
P
Death, n (%) 3 (7.5) 4 (10.0) 0.10
NYHA, n (%)
I 13 (32.5) 14 (35.0) 0.65
II 19 (47.5) 18 (45.0) 0.55
III 6 (15.0) 5 (12.5) 0.45
IV 2 (5.0) 3 (7.5) 0.10
AMI, n (%) 0 0
Arrhythmias requiring treatment, n (%) 6 (15.0) 10 (25.0) 0.02
Cardiac dysfunction, n (%) 2 (5.0) 2 (5.0) 0.99
Readmission, n (%) 8 (20.0) 10 (25.0) 0.45

TMZ, Trimetazidine; NYHA, New York Heart Association; AMI, acute myocardial infarction